decision-making regarding therapeutic intervention is influenced by the presence of other lipoprotein risk factors , such as reduced hdl cholesterol and elevated lipoprotein ( a ) , and nonlipid factors , including age , sex , hypertension , obesity , smoking , diabetes mellitus , and family or patient history of cad .
C0023820
lipoprotein
C0065058
lipoprotein